Renoprotection in diabetes: genetic and non-genetic risk factors and treatment

被引：125

作者：

Parving, HH ^{[1
]}

机构：

[1] Steno Diabet Ctr, DK-2820 Gentofte, Denmark

来源：

DIABETOLOGIA | 1998年 / 41卷 / 07期

关键词：

Type I and Type II diabetes; microalbuminuria; diabetic nephropathy; antihypertensive treatment; angiotensin converting inhibition; renal progression promoters; insertion/deletion polymorphism of angiotensin converting enzyme gene; end stage renal failure; glycaemic control;

D O I：

10.1007/s001250050983

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：745 / 759

页数：15

共 190 条

[1] ABOUNA GM, 1983, LANCET, V2, P1274
[2] Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria
Ahmad, J
Siddiqui, MA
Ahmad, H
[J]. DIABETES CARE, 1997, 20 (10) : 1576 - 1581
[3] Alaveras A, 1997, DIABETOLOGIA, V40, P64
[4] Alaveras AEG, 1997, NEPHROL DIAL TRANSPL, V12, P71
[5] ANDERSEN AR, 1983, DIABETOLOGIA, V25, P496
[6] [Anonymous], KIDNEY
[7] APPERLOO AJ, 1994, KIDNEY INT, V45, pS174
[8] A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function
Apperloo, AJ
deZeeuw, D
deJong, PE
[J]. KIDNEY INTERNATIONAL, 1997, 51 (03) : 793 - 797
[9] Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy
Bakris, GL
Copley, JB
Vicknair, N
Sadler, R
Leurgans, S
[J]. KIDNEY INTERNATIONAL, 1996, 50 (05) : 1641 - 1650
[10] HYPERTENSION AND RENAL DISEASES
BALDWIN, DS
NEUGARTEN, J
[J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1987, 10 (03) : 186 - 191

← 1 2 3 4 5 6 7 8 9 10 →